PREGNANCY-BIRTH Messages for April, 2001: Re: DEPO-PROVERA - during pregnancy

Re: DEPO-PROVERA - during pregnancy - effects on fetus

From: Harvey S. Marchbein, M.D. (anonymous@obgyn.net)
Sun, 1 Apr 2001 20:29:03 -0500 (CDT)

Messages sorted by: [ date ][ thread ][ subject ][ author ]
Next message: Harvey S. Marchbein, M.D.: "Re: Hormones?"
Previous message: anonymous@obgyn.net: "migraines- birth control pills"
In reply to: Heidi: "DEPO-PROVERA - during pregnancy - effects on fetus"

You should have genetics counsellors check this out. I did a literature search and there was some discordance with reports in the last 10-15 years and further back. There's a lot to discuss with your doctor that I got from several studies since 1988.

"The children exposed in utero to Depo-Provera had higher neonatal and infant mortality rates (44.3 and 62.9 per 1,000 live births, respectively) than did the controls (19.8 and 29.1 per 1,000 live births)...... low birth weight may act as an intermediate determinant of Depo-Provera-associated mortality.......However, among accidental pregnancies with Depo-Provera, the risk of low birth weight was significantly increased when conception was estimated to have occurred within 4 weeks of injection. The odds ratios were 1.9 (95% Cl 1.4-3.2) for injection-to-conception intervals of less than or equal to 4 weeks........... There was a significantly increased association of polysyndactyly among infants of DMPA users relative to the other groups, which was most pronounced in offspring of women under age 30 years, and persisted after exclusion of subjects with a family history or infants with multiple abnormalities. However, in five out of the ten polysyndactyly cases, the last injection of DMPA occurred more than 9 months before conception, and only three cases had definite gestational exposure. The association of chromosomal anomalies was also significantly increased in infants of mothers who used DMPA. The unrelated nature of these defects, the lack of confirmation from other studies, the distant preconceptional exposure to DMPA in many cases, and chance effects due to multiple statistical comparisons make a causal association unlikely. Other birth defects that had been previously reported in some publications to be associated with progestational steroid exposure, such as neural tube defects, heart malformations, and limb reduction defects, were not found in this study..............the modest demasculinization effects of prenatal hormone exposure observed in females."

--
Harvey S. Marchbein, M.D. FACOG, FACS
Great Neck, New York

**Note:  Opinions expressed here are for educational purposes only
and, as such, do not constitute a physician-patient relationship.
This information is not intended to supplant the need for you to
consult with your physician prior to choosing therapeutic options
and/or interventions.

**Private emails cannot be entertained due to time constraints,
consequently no private emails will receive a response.

**Thank you for your understanding ;-)

Please be aware that all e-mail on this forum is archived and can be viewed at
http://forums.obgyn.net/womens-health,
http://forums.obgyn.net/pregnancy-birth or
http://forums.obgyn.net/young-women
and is accessible to anybody on the
internet including internet search engines.  This should be taken into
consideration before sending postings of a personal or confidential nature.

Next message: Harvey S. Marchbein, M.D.: "Re: Hormones?"
Previous message: anonymous@obgyn.net: "migraines- birth control pills"
In reply to: Heidi: "DEPO-PROVERA - during pregnancy - effects on fetus"

use when must restrict search to only the pregnancy & birth forum...
Enter search keywords:
	Returns per screen: Require all keywords: